DEFA14A ·Filed May 5, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor vote outcome on the option repricing proposal. If passed, it may improve employee retention but could cause modest dilution. No immediate trading catalyst.
Final — all horizons settled through T+60d
CHRS ▼ -19.43% at T+60d
NEUTRAL call ✗ call lost -19.43% · α vs SPY -21.49% · entry $1.75 → $1.41
T+1d
+0.57%
call +0.57% · α +0.90%
$1.76
settled 5mo ago
T+5d
-2.29%
call -2.29% · α -3.42%
$1.71
settled 5mo ago
T+20d
-16.00%
call -16.00% · α -18.78%
$1.47
settled 4mo ago
T+60d
-19.43%
call -19.43% · α -21.49%
$1.41
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Coherus Oncology filed definitive additional proxy materials (DEFA14A) reminding employees to vote at the May 27, 2026 annual meeting. The key proposal is a repricing of employee stock options with strike prices at or above $5 down to the closing price on the meeting date. The filing is a routine solicitation with no material financial impact.
Key Facts
- Annual meeting scheduled for May 27, 2026 at 1:30pm PST.
- Proposal to reprice employee stock options with strike prices ≥$5 to the closing price on meeting date.
- Passage requires majority of votes cast 'FOR'.
- Proxy solicitor contact provided: Christopher Rice at (203) 561-6945.
- Email sent by Chief Human Resources Officer Rebecca Sunshine.
Financial Impact
Not specified
Risk Factors
- Proposal may fail if not enough votes are cast in favor.
- Potential dilution from repriced options if exercised.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (12 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-055695 |
| Document: 0001104659-26-055695-index-headers.html | 0001104659-26-055695 |
| Document: 0001104659-26-055695-index.html | 0001104659-26-055695 |
| Document: 0001104659-26-055695.txt | 0001104659-26-055695 |
11 reports for CHRS
67% Hit rate best @ T+5▲ +16.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Press Release | $1.34 $1.29 | ▼ −4.10% | ▼ −3.11% | $1.16 (−13.43%) |
Jul 22, 2026 10w ago | Press Release | $1.43 $1.33 | ▼ −6.99% | ▼ −9.89% | $1.16 (−18.88%) |
Jun 15, 2026 15w ago | 8-K | $1.38 $1.45 | ▲ +5.07% | ▲ +4.87% | $1.16 (−15.94%) |
Jun 12, 2026 16w ago | Institutional Cluster | $1.40 $1.54 | ▼ −10.00% | ▼ −8.22% | $1.16 (+17.14%) |
May 28, 2026 18w ago | DEFA14A | $1.65 $1.50 | ▼ −9.09% | ▼ −5.95% | $1.16 (−29.70%) |
May 11, 2026 20w ago | Press Release | $1.71 $1.36 | ▼ −20.47% | ▼ −18.74% | $1.16 (−32.16%) |
May 5, 2026 21w ago | DEFA14A | $1.75 $1.47 | ▼ −16.00% | ▼ −18.78% | $1.16 (−33.71%) |
May 4, 2026 21w ago | Press Release | $1.73 $1.57 | ▼ −9.25% | ▼ −14.89% | $1.16 (−32.95%) |
Mar 9, 2026 29w ago | Press Release | $1.95 $1.70 | ▼ −12.82% | ▼ −12.67% | $1.16 (−40.51%) |
Mar 2, 2026 30w ago | Press Release | $1.65 $1.60 | ▼ −3.03% | ▲ +4.91% | $1.16 (−29.70%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Mon (64h 59m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access